Literature DB >> 20404393

Angiocentric nasal T-cell lymphoma in a patient withidiopathic CD4+ lymphocytopenia.

Soheila Moradi1, Zahra Chavoshzadeh, Mina Izadyar, Fatemeh Mahjoub, Nima Rezaei.   

Abstract

Idiopathic CD4+ Lymphocytopenia is a rare combined immunodeficiency disease, characterized by low CD4+ T-cell count and increased susceptibility to opportunistic infections, autoimmunity and malignancies after exclusion of secondary forms of CD4 lymphocytopenia. Here we present a 13-year old boy who was referred to our center because of destructive ulceration of soft and hard palates with extension to nose and maxillary sinus starting at 6 months of age. He had a history of recurrent otitis media, chronic diarrhea, arthritis and herpetic lesions of eyes and mouth since the age of 5 years. Laboratory studies revealed very low number of CD4+ T-cells (<100 cells/mm(3)). Secondary causes of CD4 lymphocytopenia, including HIV infection, were ruled out. Immunohistological studies of destructive lesions in oral and nasal cavity revealed angiocentric T-cell lymphoma. Unfortunately, the patient died in spite of treatment with a combination of irradiation and chemotherapy. This patient is the first reported case of lethal midline granuloma with origin T-cell lymphoma in idiopathic CD4+ lymphocytopenia.

Entities:  

Mesh:

Year:  2009        PMID: 20404393     DOI: 08.04/ijaai.215218

Source DB:  PubMed          Journal:  Iran J Allergy Asthma Immunol        ISSN: 1735-1502            Impact factor:   1.464


  2 in total

1.  Extranodal NK/T Cell Lymphoma with Destruction of the Uvulae: A Case Report.

Authors:  Farahzad Jabbari Azad; Zahra Delavarian; Masoud Hatami; Hosein Rahimi; Mohammad Reza Abdolvahed
Journal:  Iran J Otorhinolaryngol       Date:  2017-03

2.  Case Report: Rhizopus arrhizus Rhino-Orbital-Cerebral Mycosis and Lethal Midline Granuloma: Another Fungal Etiological Agent.

Authors:  Dong Ming Li; Li De Lun; Jie Ge; Gong Jie Zhang; Xin Lun Li; G Sybren de Hoog
Journal:  Front Med (Lausanne)       Date:  2021-06-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.